MedPath

A Randomized, Comparative Trial of Two Posterior Lamellar Keratoplasty Techniques. Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UTDSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK).

Suspended
Conditions
Fuchs'endothelial dysthrophyand indication for keratoplasty
Registration Number
NL-OMON24220
Lead Sponsor
The Rotterdam Eye HospitalPO Box 700303000 LM Rotterdam010- 401 77 77
Brief Summary

ot Applicable

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age ≥ 18 years
- Informed consent.
- Fuchs endothelial dystrophy.
- VA < 0.6 (Snellen).

Exclusion Criteria

Unable to attend the FU visits.
- Previous keratoplasty in the eye to be included.
- Severe progressive glaucoma (stable glaucoma on topical therapy is excepted).
- History of retinal surgery, glaucoma surgery or age related macular disease.
- Amblyopia.
- Expected postoperative VA < 0.6.
- Corneal neovascularisation > 1 quadrant.
- Indication for typed graft.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of letters gained at 12 months.
Secondary Outcome Measures
NameTimeMethod
ogMAR Best Corrected Visual Acuity (BCVA) at 1, 3, 6, 12 months.<br>Rate of LogMAR BCVA recovery in both groups (RMANOVA).<br>Contrast sensitivity and stray light at 1, 3, 6 and 12 months.<br>RMS (root mean square) of Zernike polynomials of total high order aberrations.<br>Quality of vision questionnaire at 1, 3, 6 and 12 months.<br>Endothelial cell density of the grafts at 6 and 12 months.<br>Number of graft detachments.<br>Number of graft failures.<br>OT time and costs.<br>
© Copyright 2025. All Rights Reserved by MedPath